Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Edward Schuchman
Icahn School of Medicine at Mount Sinai, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Plexcera Therapeutics
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Schuchman is a co-founder and owns equity in Plexcera Therapeutics LLC, a privately held biopharmaceutical company formed to develop therapies for rare diseases, including Farber disease. He also receives financial compensation as a consultant for Plexcera.
Acid Ceramidase, Ceramide and Farber Disease
AC is a key enzyme in the regulation of sphingolipid metabolism and signaling, and abnormal AC expression has been observed in many human diseases. Our previous work has provided many of the essential research tools needed to study this enzyme, and revealed its critical role in early development. The research we are proposing in the upcoming funding period will continue to provide important new information about this protein, and should impact a wide range of translational medicine disciplines (e.g., lysosomal disease research, fertility, sphingolipid signaling, etc).
Filed on September 26, 2014.
Tell us what you know about Edward Schuchman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Edward Schuchman filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Edward Schuchman | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Plexcera Therapeutics | $200,000 - $249,999 |
| Edward Schuchman | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Genzyme Corporation | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.